These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21115164)

  • 1. Pheochromocytomas: the (pseudo)-hypoxia hypothesis.
    Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):957-68. PubMed ID: 21115164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations.
    Pollard PJ; El-Bahrawy M; Poulsom R; Elia G; Killick P; Kelly G; Hunt T; Jeffery R; Seedhar P; Barwell J; Latif F; Gleeson MJ; Hodgson SV; Stamp GW; Tomlinson IP; Maher ER
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4593-8. PubMed ID: 16954163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.
    Jochmanová I; Yang C; Zhuang Z; Pacak K
    J Natl Cancer Inst; 2013 Sep; 105(17):1270-83. PubMed ID: 23940289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of pheochromocytomas and paragangliomas.
    Opocher G; Schiavi F
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):943-56. PubMed ID: 21115163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia-paraganglioma syndrome.
    Taïeb D; Yang C; Delenne B; Zhuang Z; Barlier A; Sebag F; Pacak K
    J Clin Endocrinol Metab; 2013 May; 98(5):E908-13. PubMed ID: 23539726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF signaling pathway in pheochromocytoma and other neuroendocrine tumors.
    Jochmanová I; Zelinka T; Widimský J; Pacak K
    Physiol Res; 2014; 63(Suppl 2):S251-62. PubMed ID: 24908231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas.
    Gaal J; Burnichon N; Korpershoek E; Roncelin I; Bertherat J; Plouin PF; de Krijger RR; Gimenez-Roqueplo AP; Dinjens WN
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1274-8. PubMed ID: 19915015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the management of malignant pheochromocytoma and paraganglioma: focus on tyrosine kinase and hypoxia-inducible factor inhibitors.
    Toledo R; Jimenez C
    F1000Res; 2018; 7():. PubMed ID: 30109021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
    Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
    Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription association of VHL and SDH mutations link hypoxia and oxidoreductase signals in pheochromocytomas.
    Dahia PL;
    Ann N Y Acad Sci; 2006 Aug; 1073():208-20. PubMed ID: 17102089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma and functional paraganglioma.
    Roman S
    Curr Opin Oncol; 2004 Jan; 16(1):8-12. PubMed ID: 14685086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular progress in hereditary paraganglioma.
    Baysal BE
    J Med Genet; 2008 Nov; 45(11):689-94. PubMed ID: 18978332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of the natural antisense hypoxia-inducible factor-1alpha transcript is associated with malignant pheochromocytoma/paraganglioma.
    Span PN; Rao JU; Oude Ophuis SB; Lenders JW; Sweep FC; Wesseling P; Kusters B; van Nederveen FH; de Krijger RR; Hermus AR; Timmers HJ
    Endocr Relat Cancer; 2011 Jun; 18(3):323-31. PubMed ID: 21422080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
    Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 15 YEARS OF PARAGANGLIOMA: Genetics and mechanism of pheochromocytoma-paraganglioma syndromes characterized by germline SDHB and SDHD mutations.
    Baysal BE; Maher ER
    Endocr Relat Cancer; 2015 Aug; 22(4):T71-82. PubMed ID: 26113606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma.
    Mannelli M; Rapizzi E; Fucci R; Canu L; Ercolino T; Luconi M; Young WF
    Endocr Relat Cancer; 2015 Aug; 22(4):T83-90. PubMed ID: 26113605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of hypoxia and HIF2α in development of the sympathoadrenal cell lineage and chromaffin cell tumors with distinct catecholamine phenotypic features.
    Richter S; Qin N; Pacak K; Eisenhofer G
    Adv Pharmacol; 2013; 68():285-317. PubMed ID: 24054150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent EPAS1/HIF2α exons 9 and 12 mutations in non-familial pheochromocytoma.
    Welander J; Andreasson A; Brauckhoff M; Bäckdahl M; Larsson C; Gimm O; Söderkvist P
    Endocr Relat Cancer; 2014 Jun; 21(3):495-504. PubMed ID: 24741025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
    Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.